Neuroprotective Effects of Fisetin in Alzheimer’s and Parkinson’s Diseases: From Chemistry to Medicine

E-ISSN： 1873-4294|16|17|1910-1915

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.17, 2016-07, pp. : 1910-1915

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing a neuroprotective therapy for Parkinson’s and Huntington’s diseases

By Kazantsev Aleksey G

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 2, 2007-02 ,pp. : 159-172

Informa Healthcare

Access to resources Recommend Favorite

Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases

Current Drug Metabolism, Vol. 18, Iss. 9, 2017-12 ,pp. : 868-876

Bentham Science Publishers

Access to resources Recommend Favorite

Prostate apoptosis response-4 (Par-4): an emerging target for Alzheimer’s and Parkinson’s diseases and stroke

By Mattson M.P.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 1, 2000-02 ,pp. : 51-63

Informa Healthcare

Access to resources Recommend Favorite

Novel Drug Delivery Systems for Releasing Growth Factors to the CNS: Focus on Alzheimer’s and Parkinson’s Diseases

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 7, 2014-06 ,pp. : 557-566

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances on the Role of Neurogenesis in the Adult Brain: Therapeutic Potential in Parkinson's and Alzheimer's Diseases

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 7, 2017-10 ,pp. : 740-748

Bentham Science Publishers

Access to resources Recommend Favorite